Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin and Cyclophosphamide in Solid Tumors and Advanced Breast Cancer
NCT01554371Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2012
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in solid tumor, breast cancer, sponsored by University of California, San Francisco. Started Mar 2012; status: completed.
02
Drugs
eribulin
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT01554371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554371.